跳转至内容
Merck
CN

M249

Macrophage Inflammatory Protein-3α human

lyophilized powder (from PBS solution), suitable for cell culture

别名:

hMIP-3α, Exodus, LARC, MIP-3α

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352202
NACRES:
NA.77
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

biological source

human

recombinant

expressed in E. coli

assay

≥95% (SDS-PAGE)

form

lyophilized powder (from PBS solution)

potency

0.3 nM ED50 (by calcium flux induction)

mol wt

~8 kDa

packaging

pkg of 25 μg

storage condition

avoid repeated freeze/thaw cycles

technique(s)

cell culture | mammalian: suitable

impurities

endotoxin tested

UniProt accession no.

storage temp.

−20°C

Quality Level

Gene Information

正在寻找类似产品? 访问 产品对比指南

General description

MIP-3 α, also known as LARC or Exodus, is one of the many chemokines identified through the Expressed Sequence Tag database. MIP-3 alpha, cDNA encodes a 96 amino acid precursor protein and a 26 amino acid signal peptide. The resulting 70 amino acid mature protein has only 20-28% homology with other related human chemokines. The gene for MIP-3 alpha has been mapped to chromosome 2 rather than chromosome 17 where many human chemokine genes are located. Expression of the chemokine is detected in the lymphoid tissues, fetal lung and fetal liver. Recombinant and native MIP-3 alpha are known chemoattractants of lymphocytes in vitro. Additionally, a growing body of work has identified MIP-3 alpha as a functional ligand of GPR-CY4 orphan receptor or CCR6 and given useful information about in vivo function.

Biochem/physiol Actions

Expression of the chemokine is detected in the lymphoid tissues, fetal lung and fetal liver. Recombinant and native MIP-3α are known chemoattractants of lymphocytes in vitro. Additionally, a growing body of work has identified MIP-3α as a functional ligand of GPR-CY4 orphan receptor or CCR6 and given useful information about in vivo function.

Analysis Note

The biological activity is measured by its ability to induce calcium flux in HEK293 cells stably expressing CCR-6 and for chemotaxis of mouse BaF/3 cells transfected with hCCR6.

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Jenny E Hernandez-Davies et al.
Journal of translational medicine, 13, 210-210 (2015-07-04)
(V600) BRAF mutations drive approximately 50% of metastatic melanoma which can be therapeutically targeted by BRAF inhibitors (BRAFi) and, based on resistance mechanisms, the combination of BRAF and MEK inhibitors (BRAFi + MEKi). Although the combination therapy has been shown to provide
Shaun Martin et al.
Autophagy, 13(9), 1512-1527 (2017-07-20)
The ingrained capacity of melanoma cells to rapidly evolve toward an aggressive phenotype is manifested by their increased ability to develop drug-resistance, evident in the case of vemurafenib, a therapeutic-agent targeting BRAFV600E. Previous studies indicated a tight correlation between heightened

相关内容

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持